Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Shares Outstanding (Weighted Average): 2018-2021

  • Genmab A's Shares Outstanding (Weighted Average) rose 0.72% to $65.5 million in Q2 2021 from the same period last year, while for Dec 2020 it was $65.1 million, marking a year-over-year change of. This contributed to the annual value of $66.2 million for FY2024, which is 0.17% up from last year.
  • Genmab A's Shares Outstanding (Weighted Average) amounted to $65.5 million in Q2 2021, which was up 0.72% from $65.1 million recorded in Q4 2020.
  • In the past 5 years, Genmab A's Shares Outstanding (Weighted Average) ranged from a high of $65.5 million in Q2 2021 and a low of $64.3 million during Q4 2018.
  • In the last 3 years, Genmab A's Shares Outstanding (Weighted Average) had a median value of $65.1 million in 2020 and averaged $64.9 million.
  • Data for Genmab A's Shares Outstanding (Weighted Average) shows a peak YoY climbed of 1.20% (in 2020) over the last 5 years.
  • Over the past 4 years, Genmab A's Shares Outstanding (Weighted Average) (Quarterly) stood at $64.3 million in 2018, then remained steady at $64.3 million in 2019, then increased by 1.20% to $65.1 million in 2020, then increased by 0.72% to $65.5 million in 2021.
  • Its last three reported values are $65.5 million in Q2 2021, $65.1 million for Q4 2020, and $65.1 million during Q2 2020.